Ask AI
ProCE Banner Activity

From IAS COVID-19 Prevention: Significant Advances in a Global Vaccination Program

Conference Coverage
Clinical Thought
Advances in vaccine technologies and trials are leading to robust data for global vaccination efforts. Current vaccines have varying degrees of efficacy, and emerging variants are creating further deviation, suggesting a need for a rapid increase in vaccinations as well as improved molecular surveillance.

Released: March 18, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc.

Partners

IAS 2018

ProCE Banner

IAS COVID

ProCE Banner

Faculty Disclosure

Primary Author

Kenneth H. Mayer, MD

Medical Researcher Director
Fenway Health
Co-Director
The Fenway Institute
Professor of Medicine
Harvard Medical School
Attending Physician
Infectious Disease Division
Beth Israel Deaconess Hospital
Boston, Massachusetts

Kenneth Mayer, MD, has disclosed that he has received funds for research support from Gilead Sciences, Janssen, and Merck and consulting fees from Gilead Sciences and Merck.